Literature DB >> 3024013

The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.

E F Wheeler, C W Rettenmier, A T Look, C J Sherr.   

Abstract

The McDonough strain of feline sarcoma virus (SM-FeSV) transforms fibroblast cell lines in culture and produces fibrosarcomas in domestic cats. SM-FeSV does not induce haematopoietic malignancies in spite of the fact that its viral oncogene, v-fms, codes for a glycoprotein related to the receptor for the mononuclear phagocyte colony stimulating factor, CSF-1. The v-fms-coded polypeptide includes the complete extracellular domain of the c-fms proto-oncogene product and retains the ability to bind CSF-1 specifically. The two molecules have very similar sequences except at their extreme carboxyl terminal ends where 40 amino acids of the c-fms-coded glycoprotein are replaced by 11 unrelated residues in the v-fms product. Autophosphorylation of the c-fms gene product on tyrosine is enhanced by CSF-1 addition, whereas phosphorylation of the v-fms-coded glycoprotein appears to be constitutive. We now show that introduction of the v-fms gene into simian virus-40 (SV40)-immortalized, CSF-1 dependent macrophages renders them independent of CSF-1 for growth and tumourigenic in nude mice. These factor-independent cell lines express unaltered levels of the c-fms product which is down-modulated in response to either CSF-1 or the tumour promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA). The induction of factor independence by a non-autocrine mechanism suggests that the v-fms product is an unregulated kinase that provides growth stimulatory signals in the absence of ligand.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024013     DOI: 10.1038/324377a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  31 in total

1.  Haemopoietic growth factors: their role in cell development and their clinical use.

Authors:  N G Testa; T M Dexter
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 2.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B.

Authors:  S Brown-Shimer; K A Johnson; J B Lawrence; C Johnson; A Bruskin; N R Green; D E Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 5.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

Review 6.  Colony-stimulating factors in the pathogenesis and treatment of disease.

Authors:  D J Williamson; C G Begley
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

7.  CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines.

Authors:  Michael Kogan; Tracy Fischer-Smith; Rafal Kaminsky; Gabrielle Lehmicke; Jay Rappaport
Journal:  Anticancer Res       Date:  2012-03       Impact factor: 2.480

8.  Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.

Authors:  G V Borzillo; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  Expression of a fms-related oncogene in carcinogen-induced neoplastic epithelial cells.

Authors:  C Walker; P Nettesheim; J C Barrett; T M Gilmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 10.  Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling.

Authors:  Davide Ruggero
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.